Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02815709 · ClinicalTrials.gov registry record · Phase 3

Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Bunionectomy

A Phase 3 study of Acute Pain, sponsored by Trevena.

Completed
Registry status
Phase 3
Development phase
418
Enrollment target
7
Study locations

NCT02815709 is a Phase 3 study of Acute Pain that has completed, run by Trevena. The registered enrollment target is 418 participants, above the 260-participant average among 50 other Acute Pain trials with a reported enrollment target (61% higher). The trial reports 7 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02815709, a Phase 3 study of Acute Pain, has completed, sponsored by Trevena.

COMPLETED
Registry status
Phase 3
Development phase
418 participants
Enrollment target
7
Study locations

Study Summary

The primary objective is to evaluate the analgesic efficacy of intravenous (IV) oliceridine administered as needed (PRN) compared with placebo in patients with moderate to severe acute postoperative pain after bunionectomy.

Conditions Studied

Acute Pain

Interventions

  • DRUG Placebo
  • DRUG Morphine
  • DRUG Oliceridine

Study Locations (7)

California

  • Research Site - Anaheim
  • Research Site - Pasadena

Texas

  • Research Site - Austin
  • Research Site - San Antonio

Arizona

  • Research Site - Phoenix

Maryland

  • Research Site - Pasadena

Utah

  • Resarch Site - Salt Lake City

Trial Details

FieldValue
Enrollment Target 418 participants
Start Date 2016-05
Est. Completion 2017-01
Phase Phase 3

Sponsor

Trevena

15 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02815709

The ClinicalTrials.gov registry entry for NCT02815709 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 418 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 260-participant average among 50 other Acute Pain trials with a reported enrollment target (61% higher). The listed sponsor is Trevena, which has 15 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Acute Pain appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT02815709 reports 7 study locations spanning 5 distinct geographic areas - top geographies include California, Texas, Arizona.

Frequently Asked Questions

What is clinical trial NCT02815709 about?

NCT02815709 is a clinical study titled "Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After Bunionectomy". The primary objective is to evaluate the analgesic efficacy of intravenous (IV) oliceridine administered as needed (PRN) compared with placebo in patients with moderate to severe acute postoperative pain after bunionectomy.

What is the current status of trial NCT02815709?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 418 participants. The study started on 2016-05. Estimated completion is 2017-01.

What conditions does trial NCT02815709 study?

This clinical trial studies the following conditions: Acute Pain.

What interventions are being tested in trial NCT02815709?

The interventions under investigation include: Placebo (DRUG), Morphine (DRUG), Oliceridine (DRUG).

Who is sponsoring clinical trial NCT02815709?

This trial is sponsored by Trevena, which has 15 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02815709 being conducted?

This trial has 7 study locations across Arizona, California, Maryland, Texas, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Acute Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Acute Pain

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.